A fluorescent oxaliplatin derivative for investigation of oxaliplatin resistance using imaging techniques.

about

A fluorescent oxaliplatin derivative for investigation of oxaliplatin resistance using imaging techniques.

Item

http://www.wikidata.org/entity/Q50086067

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

A fluorescent oxaliplatin deri ...... ance using imaging techniques.

@en

A fluorescent oxaliplatin deri ...... ance using imaging techniques.

@nl

type

Item

label

A fluorescent oxaliplatin deri ...... ance using imaging techniques.

@en

A fluorescent oxaliplatin deri ...... ance using imaging techniques.

@nl

prefLabel

A fluorescent oxaliplatin deri ...... ance using imaging techniques.

@en

A fluorescent oxaliplatin deri ...... ance using imaging techniques.

@nl

P1476

A fluorescent oxaliplatin deri ...... ance using imaging techniques.

@en

P2093

Ganna V Kalayda

http://www.w3.org/2001/XMLSchema#string

Markus Galanski

http://www.w3.org/2001/XMLSchema#string

Maximilian Kullmann

http://www.w3.org/2001/XMLSchema#string

Sabrina Gollos

http://www.w3.org/2001/XMLSchema#string

P2860

Soluble single-walled carbon nanotubes as longboat delivery systems for platinum(IV) anticancer drug design

Altered localisation of the copper efflux transporters ATP7A and ATP7B associated with cisplatin resistance in human ovarian carcinoma cells.

Optimized sample preparation strategy for the analysis of low molecular mass adducts of a fluorescent cisplatin analogue in cancer cell lines by CE-dual-LIF.

Effects of noncovalent platinum drug-protein interactions on drug efficacy: use of fluorescent conjugates as probes for drug metabolism.

{(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine}oxalatoplatinum(II): a novel enantiomerically pure oxaliplatin derivative showing improved anticancer activity in vivo.

The role of cellular accumulation in determining sensitivity to platinum-based chemotherapy.

Evaluation of fluorophore-tethered platinum complexes to monitor the fate of cisplatin analogs

Platinum drug distribution in cancer cells and tumors.

Oxaliplatin in the era of personalized medicine: from mechanistic studies to clinical efficacy.

P2888

s00775-017-1502-z

P304

1295-1304

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00775-017-1502-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2017-10-17T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29043454

http://www.w3.org/2001/XMLSchema#string